Education
About Us
Working with TipRanks
Follow Us
Steve Harr Insider Profile
11 Followers
Steve Harr, CFO & Head, Corp. Development at Juno Therapeutics, holds 0.00 shares in Juno Therapeutics (Ticker: JUNO), holds ― shares in Loxo Oncology (Ticker: LOXO), holds 8.89M shares in Sana Biotechnology (Ticker: SANA).
Steve Harr Juno Therapeutics (JUNO)CFO & Head, Corp. Development
Juno Therapeutics (JUNO)
CFO & Head, Corp. Development
Not Ranked
Steve Harr has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Roles
President & CEO, Director
Roles that Steve Harr holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Steve Harr
Steve Harr's Trading History
Juno Therapeutics
Mar 07, 2018
―
Uninformative Sell
47.19M
$0.00
Loxo Oncology
―
―
―
―
Sana Biotechnology
Mar 10, 2025
President & CEO, Director
Uninformative Buy
95.92K
$22.95M
List of latest transactions for each holding click on a transaction to see Steve Harr's performance on stock
You May Also Like
Steve Harr insider profile FAQ
What is the percentage of profitable transactions made by Steve Harr?
The percentage of profitable transactions made by Steve Harr is ―.
What is the average return per transaction made by Steve Harr?
The average return per transaction made by Steve Harr is ―.
What stocks does Steve Harr hold?
Steve Harr holds: JUNO, LOXO, SANA stocks.
What was Steve Harr’s latest transaction?
Steve Harr latest transaction was an Uninformative Sell of $47.19M.
What was Steve Harr's most profitable transaction?
Steve Harr’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Steve Harr's role in Juno Therapeutics?
Steve Harr's role in Juno Therapeutics is CFO & Head, Corp. Development.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.